<DOC>
	<DOCNO>NCT00880581</DOCNO>
	<brief_summary>To assess feasibility use intra-tumoral PF-3512676 combination local radiation therapy lowgrade b-cell lymphoma .</brief_summary>
	<brief_title>A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation Low-Grade B-Cell Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Biopsy confirm lowgrade Bcell lymphoma diagnose follicular grade 1 2 , marginal zone small lymphocytic lymphoma initial stage . Patients may either treatmentnaïve ; relapse ; refractory prior therapy . ( 15 treatmentnaïve 15 relapsed/refractory patient enrol ) Patients must least one site disease accessible intratumoral injection PF3512676 percutaneously Tumor specimen must available immunological study either previous biopsy new biopsy obtain initiation study . Patients must measurable disease injection site biopsy site . Eastern Cooperative Oncology Group ( ECOG ) Performance Status ≥ 1 Karnofsky Performance Status ( KPS ) ≥ 70 ≥ 18 year age White blood cell ( WBC ) ≥ 2,000/uL Platelet count ≥ 75,000/mm³ Absolute neutrophil count ( ANC ) ≥ 1000 Serum creatinine ≤ 2.0 mg/dL . Bilirubin ≤ 1.5 mg/dL Serum glutamic oxalocetic transaminase ( SGOT ) / serum glutamic pyruvic transaminase ( SGPT ) ratio &lt; 3 x upper limit normal ( ULN ) Required wash period prior therapy : Topical therapy : 2 week Chemotherapy : 4 week Radiotherapy : 4 week Other investigational therapy : 4 week Rituximab : 12 week Patients reproductive potential partner must agree use effective ( &gt; 90 % reliability ) form contraception study 4 week follow last study drug administration . Women reproductive potential must negative urine pregnancy test . Life expectancy &gt; 4 month . Able comply treatment schedule . Ability understand willingness sign write informed consent document . Preexisting autoimmune antibody mediate disease include : Systemic lupus , erythematosus Rheumatoid arthritis Multiple sclerosis Sjogren 's syndrome Autoimmune thrombocytopenia , exclude control thyroid disease Presence autoantibodies without clinical autoimmune disease . Known history human immunodeficiency virus ( HIV ) . Patients active infection fever &gt; 38.5 C within 3 day prior first schedule treatment . Central nervous system ( CNS ) metastases Prior malignancy ( active within 5 year screen ) except basal cell completely excise noninvasive squamous cell carcinoma skin , situ squamous cell carcinoma cervix . History allergic reaction attribute compound similar composition PF3512676 Current anticoagulant therapy [ aspirin ( ASA ) ≤ 325 mg per day allow ] Significant cardiovascular disease [ ie , New York Heart Association ( NYHA ) class 3 congestive heart failure ; myocardial infarction past 6 month ; unstable angina ; coronary angioplasty past 6 month ; uncontrolled atrial ventricular cardiac arrhythmia ] . Pregnant lactate . Any medical history , include laboratory result , deem investigator likely interfere participation study , interfere interpretation result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>